Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

Clinical trial NCT01341496 · TERMINATED

Trial details

NCT number: NCT01341496
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma Melanoma Epithelial Malignancies Pleural Malignancy

Start date: 2011-04-18
Primary completion: 2016-05-12
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.